PREVENTION OF DEFECTIVE AXONAL-TRANSPORT IN STREPTOZOCIN-DIABETIC RATS BY TREATMENT WITH STATIL (ICI 128436), AN ALDOSE REDUCTASE INHIBITOR

被引：42

作者：

TOMLINSON, DR

TOWNSEND, J

FRETTEN, P

机构：

来源：

DIABETES | 1985年 / 34卷 / 10期

关键词：

D O I：

10.2337/diabetes.34.10.970

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：970 / 972

页数：3

共 11 条

[1] POLYOL PATHWAY ACTIVITY AND MYOINOSITOL METABOLISM - A SUGGESTED RELATIONSHIP IN THE PATHOGENESIS OF DIABETIC NEUROPATHY [J].

FINEGOLD, D ;

LATTIMER, SA ;

NOLLE, S ;

BERNSTEIN, M ;

GREENE, DA .

DIABETES, 1983, 32 (11) :988-992

[2]

GILLON KRW, 1983, DIABETOLOGIA, V25, P365

[3] SORBITOL, INOSITOL AND NERVE-CONDUCTION IN DIABETES [J].

GILLON, KRW ;

HAWTHORNE, JN .

LIFE SCIENCES, 1983, 32 (17) :1943-1947

[4] ACTION OF SORBINIL IN DIABETIC PERIPHERAL-NERVE - RELATIONSHIP OF POLYOL (SORBITOL) PATHWAY INHIBITION TO A MYO-INOSITOL-MEDIATED DEFECT IN SODIUM-POTASSIUM ATPASE ACTIVITY [J].

GREENE, DA ;

LATTIMER, SA .

DIABETES, 1984, 33 (08) :712-716

[5] DIABETIC AUTONOMIC NEUROPATHY [J].

HOSKING, DJ ;

BENNETT, T ;

HAMPTON, JR .

DIABETES, 1978, 27 (10) :1043-1054

[6] AXONAL-TRANSPORT OF CHOLINERGIC TRANSMITTER ENZYMES IN VAGUS AND SCIATIC-NERVES OF RATS WITH ACUTE EXPERIMENTAL DIABETES-MELLITUS - CORRELATION WITH MOTOR-NERVE CONDUCTION-VELOCITY AND EFFECTS OF INSULIN [J].

MAYER, JH ;

TOMLINSON, DR .

NEUROSCIENCE, 1983, 9 (04) :951-957

[7] PREVENTION OF DEFECTS OF AXONAL-TRANSPORT AND NERVE-CONDUCTION VELOCITY BY ORAL-ADMINISTRATION OF MYOINOSITOL OR AN ALDOSE REDUCTASE INHIBITOR IN STREPTOZOTOCIN-DIABETIC RATS [J].

MAYER, JH ;

TOMLINSON, DR .

DIABETOLOGIA, 1983, 25 (05) :433-438

[8] FAST AND SLOW AXOPLASMIC FLOW IN SCIATIC-NERVE OF DIABETIC RATS [J].

SCHMIDT, RE ;

MATSCHINSKY, FM ;

GODFREY, DA ;

WILLIAMS, AD ;

MCDOUGAL, DB .

DIABETES, 1975, 24 (12) :1081-1085

[9]

STRIBLING D, 1984, DIABETIC MED, V1, pA166

[10] PREVENTION AND REVERSAL OF DEFECTIVE AXONAL-TRANSPORT AND MOTOR-NERVE CONDUCTION-VELOCITY IN RATS WITH EXPERIMENTAL DIABETES BY TREATMENT WITH THE ALDOSE REDUCTASE INHIBITOR SORBINIL [J].

TOMLINSON, DR ;

MORIARTY, RJ ;

MAYER, JH .

DIABETES, 1984, 33 (05) :470-476

← 1 2 →